Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men.
Nine of 10 consecutively evaluated men with DSM-III-R nonparaphilic sexual addictions or paraphilias noted improvement in sexual behaviors and depressive symptomatology while treated with fluoxetine, imipramine, or lithium. Depression was measured by means of the Inventory to Diagnose Depression. Sexual behavior was assessed in two dimensions, nonconventional interest and intensified desire, as measured by total sexual outlet. The author conceptualizes these behaviors as sexual dysregulation disorders associated with a primary mood disorder.
Kafka
M P
MP
Department of Psychiatry, Harvard Medical School, Boston, Mass.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D008094:Lithium / Q000627:therapeutic use; D008297:Male; D008418:Masturbation / Q000188:drug therapy; D008875:Middle Aged; D010262:Paraphilic Disorders / Q000150:complications / Q000188:drug therapy* / Q000523:psychology; D011569:Psychiatric Status Rating Scales; D012725:Sexual Behavior / Q000187:drug effects*; D020018:Sexual Dysfunctions, Psychological / Q000150:complications / Q000188:drug therapy / Q000523:psychology; D014196:Trazodone / Q000627:therapeutic use
D000928:Antidepressive Agents; D005473:Fluoxetine; D008094:Lithium; D007099:Imipramine; D014196:Trazodone